Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Schizophrenia

Free Subscription Articles published in J Clin Psychiatry Retrieve available abstracts of 80 articles: HTML format

Single Articles

February 2024
1. CITROME L, Yagoda S, Bidollari I, Wang M, et al
   Safety and Tolerability of Starting Aripiprazole Lauroxil With Aripiprazole Lauroxil NanoCrystal Dispersion in 1 Day Followed by Aripiprazole Lauroxil Every 2 Months Using Paliperidone Palmitate Monthly as an Active Control in Patients With Schizophre
   J Clin Psychiatry. 2024;85:23m15095.
   PubMed     Abstract available
   
   
   January 2024
2. MIURA I, Sano F, Sakaguchi R, Okamoto K, et al
   Effect of Lurasidone on Social Functioning in Schizophrenia: Post Hoc Analysis of the JEWEL Study.
   J Clin Psychiatry. 2024;85:23m14881.
   PubMed     Abstract available
   
   
   
3. ITURRALDE E, Fazzolari L, Slama NE, Alexeeff SE, et al
   Telehealth Collaborative Care Led by Clinical Pharmacists for People With Psychosis or Bipolar Disorder: A Propensity Weighted Comparison With Usual Psychiatric Care.
   J Clin Psychiatry. 2024;85:23m14917.
   PubMed     Abstract available
   
   
   November 2023
4. LONDON SM, Cawkwell PB, Shinn AK
   Medication Adherence in a Transdiagnostic First-Episode Psychosis Sample.
   J Clin Psychiatry. 2023;84:23m14947.
   PubMed     Abstract available
   
   
   October 2023
5. VERGARA L, de la Serna E, Sugranyes G, Puig O, et al
   Obsessive-Compulsive Spectrum Symptoms Are Associated With Functional Impairment in Children and Adolescents With Psychosis Risk Syndrome: The CAPRIS Study.
   J Clin Psychiatry. 2023;84:22m14698.
   PubMed     Abstract available
   
   
   September 2023
6. LOPENA OJ, Alphs LD, Sajatovic M, Turkoz I, et al
   Earlier Use of Long-Acting Injectable Paliperidone Palmitate Versus Oral Antipsychotics in Patients With Schizophrenia: An Integrated Patient-Level Post Hoc Analysis.
   J Clin Psychiatry. 2023;84:23m14788.
   PubMed     Abstract available
   
   
   
7. CHENG CM, Chang WH, Tsai SJ, Li CT, et al
   Risk of All-Cause and Suicide Death in Patients With Schizophrenia: An Entire-Population Longitudinal Study in Taiwan.
   J Clin Psychiatry. 2023;84:22m14747.
   PubMed     Abstract available
   
   
   
8. CITROME L, Such P, Yildirim M, Madera-McDonough J, et al
   Safety and Efficacy of Aripiprazole 2-Month Ready-to-Use 960 mg: Secondary Analysis of Outcomes in Adult Patients With Schizophrenia in a Randomized, Open-label, Parallel-Arm, Pivotal Study.
   J Clin Psychiatry. 2023;84:23m14873.
   PubMed     Abstract available
   
   
   August 2023
9. LAW C, See YM, Yee JY, Ng BT, et al
   The Impact of Clozapine Delay on Clinical Outcomes in Schizophrenia.
   J Clin Psychiatry. 2023;84:22m14588.
   PubMed     Abstract available
   
   
   
10. MARTINS R, Kadakia A, Williams GR, Milanovic S, et al
    The Lifetime Burden of Schizophrenia as Estimated by a Government-Centric Fiscal Analytic Framework.
    J Clin Psychiatry. 2023;84:22m14746.
    PubMed     Abstract available
    
    
    
11. CITROME L, Meyer JM
    Reviewing Non-Dopaminergic Mechanisms for Positive and Negative Schizophrenia Symptom Management.
    J Clin Psychiatry. 2023;84:sunscz3001sho.
    PubMed     Abstract available
    
    
    July 2023
12. WESNER K, Hiemke C, Bergemann N, Egberts KM, et al
    Therapeutic Reference Range for Olanzapine in Schizophrenia: Systematic Review on Blood Concentrations, Clinical Effects, and Dopamine Receptor Occupancy.
    J Clin Psychiatry. 2023;84:22r14626.
    PubMed     Abstract available
    
    
    
13. ZHANG T, Xiao X, Wu H, Zeng J, et al
    Association of Attenuated Niacin Response With Inflammatory Imbalance and Prediction of Conversion to Psychosis From Clinical High-risk Stage.
    J Clin Psychiatry. 2023;84:22m14731.
    PubMed     Abstract available
    
    
    
14. ROSSOM RC, Crain AL, Waring S, Sperl-Hillen JM, et al
    Differential Effects of an Intervention to Reduce Cardiovascular Risk for Patients With Bipolar Disorder, Schizoaffective Disorder, or Schizophrenia: A Randomized Clinical Trial.
    J Clin Psychiatry. 2023;84:22m14710.
    PubMed     Abstract available
    
    
    April 2023
15. KANE JM, Mychaskiw MA, Lim S, Suett M, et al
    Treatment Journey From Diagnosis to the Successful Implementation of a Long-Acting Injectable Antipsychotic Agent in Young Adults With Schizophrenia.
    J Clin Psychiatry. 2023;84:22m14544.
    PubMed     Abstract available
    
    
    
16. JAIN R, Ayyagari R, Goldschmidt D, Zhou M, et al
    Impact of Tardive Dyskinesia on Physical, Psychological, Social, and Professional Domains of Patient Lives: A Survey of Patients in the United States.
    J Clin Psychiatry. 2023;84:22m14694.
    PubMed     Abstract available
    
    
    March 2023
17. NASIB LG, Winter-van Rossum I, Zuithoff NPA, Boudewijns ZSRM, et al
    Generalizability of the Results of Efficacy Trials in First-Episode Schizophrenia: Comparing Outcome and Study Discontinuation of Groups of Participants in the Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) Trial.
    J Clin Psychiatry. 2023;84:22m14531.
    PubMed     Abstract available
    
    
    
18. KAHN RS, Kane JM, Correll CU, Arevalo C, et al
    Olanzapine/Samidorphan in Young Adults With Schizophrenia, Schizophreniform Disorder, or Bipolar I Disorder Who Are Early in Their Illness: Results of the Randomized, Controlled ENLIGHTEN-Early Study.
    J Clin Psychiatry. 2023;84:22m14674.
    PubMed     Abstract available
    
    
    
19. IZQUIERDO A, Cabello M, Leal I, Torio I, et al
    Neighborhood Vulnerability and Disability in First Episode of Psychosis: A Multilevel Study.
    J Clin Psychiatry. 2023;84:22m14401.
    PubMed     Abstract available
    
    
    
20. CITROME L, Durgam S, Edwards JB, Davis RE, et al
    Lumateperone for the Treatment of Schizophrenia: Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed.
    J Clin Psychiatry. 2023;84:22r14631.
    PubMed     Abstract available
    
    
    
21. TAYLOR CL, Brown HK, Saunders NR, Barker LC, et al
    Preventive Health Care Among Children of Women With Schizophrenia: A Population-Based Cohort Study.
    J Clin Psychiatry. 2023;84:22m14497.
    PubMed     Abstract available
    
    
    February 2023
22. RUBIO JM, Mychaskiw MA, Lim S, Suett M, et al
    Predictors for Initiation of Atypical Long-Acting Injectable Antipsychotic Agents in a Commercial Claims Cohort of Individuals With Early-Phase Schizophrenia.
    J Clin Psychiatry. 2023;84:22m14604.
    PubMed     Abstract available
    
    
    
23. SABE M, Pallis K, Solmi M, Crippa A, et al
    Comparative Effects of 11 Antipsychotics on Weight Gain and Metabolic Function in Patients With Acute Schizophrenia: A Dose-Response Meta-Analysis.
    J Clin Psychiatry. 2023;84:22r14490.
    PubMed     Abstract available
    
    
    January 2023
24. ANDRADE C
    Prolactin-Raising and Prolactin-Sparing Antipsychotic Drugs and the Risk of Fracture and Fragility Fracture in Patients With Schizophrenia, Dementia, and Other Disorders.
    J Clin Psychiatry. 2023;84:23f14790.
    PubMed     Abstract available
    
    
    
25. VELLIGAN DI, Rao S
    Defining and Achieving Treatment Recovery in Schizophrenia.
    J Clin Psychiatry. 2023;84:MS21078COM6.
    PubMed    
    
    
    
26. VELLIGAN DI, Rao S
    Optimizing Therapy Selection, Sequencing in Schizophrenia.
    J Clin Psychiatry. 2023;84:MS21078COM9.
    PubMed    
    
    
    
27. VELLIGAN DI, Rao S
    The Epidemiology and Global Burden of Schizophrenia.
    J Clin Psychiatry. 2023;84:MS21078COM5.
    PubMed    
    
    
    
28. VELLIGAN DI, Rao S
    Adverse Events and Treatment Adherence in Schizophrenia.
    J Clin Psychiatry. 2023;84:MS21078COM8.
    PubMed    
    
    
    
29. VELLIGAN DI, Rao S
    Schizophrenia: Salient Symptoms and Pathophysiology.
    J Clin Psychiatry. 2023;84:MS21078COM7.
    PubMed    
    
    
    
30. VELLIGAN DI, Rao S
    The Emerging Treatment Landscape in Schizophrenia.
    J Clin Psychiatry. 2023;84:MS21078COM10.
    PubMed    
    
    
    December 2022
31. AMSALEM D, Jankowski SE, Pagdon S, Valeri L, et al
    "It Is Hard to Be a Woman With Schizophrenia": Randomized Controlled Trial of a Brief Video Intervention to Reduce Public Stigma in Young Adults.
    J Clin Psychiatry. 2022;84:22m14534.
    PubMed     Abstract available
    
    
    November 2022
32. NELSON EB, Franco OH, Patton BA, Schmidt LR, et al
    Telehealth of Coordinated Specialty Care in Early Psychosis During COVID-19.
    J Clin Psychiatry. 2022;84:21m14259.
    PubMed     Abstract available
    
    
    October 2022
33. KADAKIA A, Catillon M, Fan Q, Williams GR, et al
    The Economic Burden of Schizophrenia in the United States.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available
    
    
    
34. CITROME L, Preskorn SH, Lauriello J, Krystal JH, et al
    Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available
    
    
    September 2022
35. AHN ROBINS D, Grootendorst-van NH, Chang CK, Chandran D, et al
    Prevalence and Correlates of Obsessive-Compulsive Symptoms in Individuals With Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available
    
    
    
36. ANDRADE C
    Antipsychotic Augmentation With N-Acetylcysteine for Patients With Schizophrenia.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available
    
    
    August 2022
37. CORRELL CU, Ismail Z, McIntyre RS, Rafeyan R, et al
    Patient Functioning, Life Engagement, and Treatment Goals in Schizophrenia.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available
    
    
    
38. MISAWA F, Fujii Y, Takeuchi H
    Tardive Dyskinesia and Long-Acting Injectable Antipsychotics: Analyses Based on a Spontaneous Reporting System Database in Japan.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available
    
    
    
39. CORRELL CU, Ismail Z, McIntyre RS, Rafeyan R, et al
    Patient Functioning and Life Engagement: Unmet Needs in Major Depressive Disorder and Schizophrenia.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available
    
    
    
40. LEVI L, Zamora D, Nastas I, Gonen I, et al
    Add-On Pramipexole for the Treatment of Schizophrenia and Schizoaffective Disorder: A Randomized Controlled Trial.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available
    
    
    July 2022
41. SCHORETSANITIS G, de Leon J
    Best Practices for Starting Clozapine in Patients With Schizophrenia: How to Switch From the Prior Antipsychotic(s).
    J Clin Psychiatry. 2022;83.
    PubMed    
    
    
    June 2022
42. CITROME L, Komaroff M, Starling B, Byreddy S, et al
    Efficacy of HP-3070, an Asenapine Transdermal System, on Symptoms of Hostility in Adults With Schizophrenia: A Post Hoc Analysis of a 6-Week Phase 3 Study.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available
    
    
    
43. FANG SC, Huang CY, Shao YJ
    Long-term Outcomes of Early Use of Long-Acting Injectable Antipsychotics in Schizophrenia.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available
    
    
    May 2022
44. ZHENG S, Lee J, Chan SKW
    Utility and Barriers to Clozapine Use: A Joint Study of Clinicians' Attitudes From Singapore and Hong Kong.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available
    
    
    
45. WEIDEN PJ, Breier A, Kavanagh S, Miller AC, et al
    Antipsychotic Efficacy of KarXT (Xanomeline-Trospium): Post Hoc Analysis of Positive and Negative Syndrome Scale Categorical Response Rates, Time Course of Response, and Symptom Domains of Response in a Phase 2 Study.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available
    
    
    April 2022
46. COHEN EA, Skubiak T, Hadzi Boskovic D, Norman K, et al
    Phase 3b Multicenter, Prospective, Open-label Trial to Evaluate the Effects of a Digital Medicine System on Inpatient Psychiatric Hospitalization Rates for Adults With Schizophrenia.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available
    
    
    March 2022
47. SAWAGASHIRA R, Yamamura R, Okubo R, Hashimoto N, et al
    Subthreshold Change in Glycated Hemoglobin and Body Mass Index After the Initiation of Second-Generation Antipsychotics Among Patients With Schizophrenia or Bipolar Disorder: A Nationwide Prospective Cohort Study in Japan.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available
    
    
    
48. ZENG J, Raballo A, Gan R, Wu G, et al
    Antipsychotic Exposure in Clinical High Risk of Psychosis: Empirical Insights From a Large Cohort Study.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available
    
    
    
49. HUANG N, Wang PS, Chen CY, Bai YM, et al
    Influence of Care Delivery Models on Quality of Diabetes Care Among Individuals With Schizophrenia.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available
    
    
    
50. CORRELL CU, He Y, Therrien F, MacKenzie E, et al
    Effects of Brexpiprazole on Functioning in Patients With Schizophrenia: Post Hoc Analysis of Short- and Long-Term Studies.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available
    
    
    
51. SCHOOLER NR
    Functional Outcomes of an Antipsychotic Medication in Schizophrenia: A Generalizable or Specific Effect?
    J Clin Psychiatry. 2022;83.
    PubMed    
    
    
    February 2022
52. CORRELL CU, Abi-Dargham A, Howes O
    Emerging Treatments in Schizophrenia.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available
    
    
    
53. LUI SSY, Zhang RT, Lau WYS, Liu ACY, et al
    Prospective Memory Influences Social Functioning in People With First-Episode Schizophrenia: A Network Analysis and Longitudinal Study.
    J Clin Psychiatry. 2022;83.
    PubMed     Abstract available
    
    
    December 2021
54. WANG H, Zhang Y, Liu J, Chi R, et al
    Persistence With and Adherence to Paliperidone Palmitate Once-Monthly Injection for Schizophrenia Treatment in China and Japan.
    J Clin Psychiatry. 2021;83.
    PubMed     Abstract available
    
    
    
55. WANG W, Chau AKC, Kong P, Sun X, et al
    Efficacy of Motivational Interviewing in Treating Co-occurring Psychosis and Substance Use Disorder: A Systematic Review and Meta-Analysis.
    J Clin Psychiatry. 2021;83.
    PubMed     Abstract available
    
    
    
56. KIKKERT MJ, de Mooij L, de Koning M, Dekker J, et al
    Subjective Medication Satisfaction With Antipsychotic Polypharmacy in a Naturalistic Inpatient and Outpatient Sample.
    J Clin Psychiatry. 2021;83.
    PubMed     Abstract available
    
    
    
57. BEEX-OOSTERHUIS MM, Van Gool AR, Heerdink ER, van Kesteren C, et al
    Clozapine Treatment During Pregnancy and the Postpartum Period: A Systematic Literature Review.
    J Clin Psychiatry. 2021;83.
    PubMed     Abstract available
    
    
    
58. KU BS, Compton MT, Walker EF, Druss BG, et al
    Social Fragmentation and Schizophrenia: A Systematic Review.
    J Clin Psychiatry. 2021;83.
    PubMed     Abstract available
    
    
    November 2021
59. RUBIO JM, Kane JM
    How to Make an Effective Offer of Clozapine.
    J Clin Psychiatry. 2021;83.
    PubMed    
    
    
    
60. TAKAHASHI K, Uchida H, Suzuki T, Mimura M, et al
    Comorbid Psychiatric Disorders in Patients Hospitalized for Pulmonary Embolism and Acute Myocardial Infarction: A Japanese Nationwide Database Study.
    J Clin Psychiatry. 2021;83.
    PubMed     Abstract available
    
    
    September 2021
61. LE MOIGNE A, Csernansky J, Leadbetter RA, Andorn AC, et al
    PANSS Individual Item and Marder Dimension Analyses From a Pivotal Trial of RBP-7000 (Monthly Extended-Release Risperidone) in Schizophrenia Patients.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available
    
    
    
62. BAEZA I, de la Serna E, Amoretti S, Cuesta MJ, et al
    Premorbid Characteristics as Predictors of Early Onset Versus Adult Onset in Patients With a First Episode of Psychosis.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available
    
    
    
63. CORRELL CU, Howes OD
    Treatment-Resistant Schizophrenia: Definition, Predictors, and Therapy Options.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available
    
    
    
64. CHENG CM, Chen MH, Chang WH, Tsai CF, et al
    Risks of Coaggregation of Major Psychiatric Disorders Among First-Degree Relatives of Patients With Bipolar I and Bipolar II Disorder: Evidence From a Nationwide Population-Based Study.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available
    
    
    August 2021
65. OKUSAGA OO, Mitchell BG, Bernard JD, Walder A, et al
    Clozapine Is Associated With Higher COVID-19 Infection Rate in Veterans With Schizophrenia or Schizoaffective Disorder.
    J Clin Psychiatry. 2021;82.
    PubMed    
    
    
    July 2021
66. CHEN MH, Pan TL, Bai YM, Huang KL, et al
    Postpartum Depression and Psychosis and Subsequent Severe Mental Illnesses in Mothers and Neurodevelopmental Disorders in Children: A Nationwide Study.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available
    
    
    
67. ZUSCHLAG ZD
    Second-Generation Antipsychotics and Suicide: A Commentary.
    J Clin Psychiatry. 2021;82.
    PubMed    
    
    
    
68. VERAART JKE, Smith-Apeldoorn SY, Spijker J, Kamphuis J, et al
    Ketamine Treatment for Depression in Patients With a History of Psychosis or Current Psychotic Symptoms: A Systematic Review.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available
    
    
    
69. BALLARD C, Aarsland D
    Relieving Caregiver Burden Through Evidence-Based Treatment for Dementia-Related Psychosis.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available
    
    
    June 2021
70. STEINERT T, Jans F
    Six Cases of Perforated Appendicitis During Clozapine Treatment.
    J Clin Psychiatry. 2021;82.
    PubMed    
    
    
    May 2021
71. GRUBAUGH AL, Brown WJ, Wojtalik JA, Myers US, et al
    Meta-Analysis of the Treatment of Posttraumatic Stress Disorder in Adults With Comorbid Severe Mental Illness.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available
    
    
    
72. DUBREUCQ M, Plasse J, Gabayet F, Blanc O, et al
    Sex Differences in Recovery-Related Outcomes and Needs for Psychiatric Rehabilitation in People With Schizophrenia Spectrum Disorder.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available
    
    
    
73. SHINN AK, Carol EE
    The Importance of Context in Identifying the Recovery Needs of Women With Psychosis.
    J Clin Psychiatry. 2021;82.
    PubMed    
    
    
    
74. CHEN YQ, Li XR, Zhang L, Zhu WB, et al
    Therapeutic Response Is Associated With Antipsychotic-Induced Weight Gain in Drug-Naive First-Episode Patients With Schizophrenia: An 8-Week Prospective Study.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available
    
    
    
75. HARVEY PD, Kane JM
    Addressing Patients' Unmet Needs to Improve Outcomes in Schizophrenia.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available
    
    
    April 2021
76. BALLARD C
    Evidence-Based Treatment and Monitoring Strategies for Dementia-Related Psychosis.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available
    
    
    March 2021
77. KANE JM
    Lessening the Side Effect Burden to Improve Adherence Among Individuals With Schizophrenia.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available
    
    
    
78. HARVEY PD
    Patient-Centered Treatment Strategies to Improve Outcomes in Schizophrenia.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available
    
    
    
79. MILLER BJ, McEvoy JP, McCall WV
    Insomnia, Suicidal Ideation, and Suicide Attempts in the Clinical Antipsychotic Trials of Intervention Effectiveness.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available
    
    
    February 2021
80. BELL KS, Henderson DC, Wright HJ, Gogate JP, et al
    Treatment Effect With Paliperidone Palmitate Compared With Oral Antipsychotics in Black/African American Patients With Schizophrenia and a History of Criminal Justice System Involvement: A Post Hoc Analysis of the PRIDE Study.
    J Clin Psychiatry. 2021;82.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.